3 results
Approved WMOCompleted
To determine the safety and tolerability of L19-IL2 combined with SABR.
Approved WMOCompleted
To investigate the pharmacokinetics of hospital pharmacy compounded CDCA capsules, compared to the commercial alternative.
Approved WMOPending
Study Objectives:Primary Objective: InductionTo evaluate the efficacy of cobitolimod treatment compared to placebo in inducing clinical remission, in participants with moderate to severe active left-sided UC.Secondary Objectives: Induction• To…